Insider Trading & Ownership of Mark Christopher Murray

Location
Radnor, PA
Summary
The estimated net worth of Mark Christopher Murray is at least $2,139,040 dollars as of 03 Mar 2026. Mark Christopher Murray is the SVP - Acetyls of Celanese Corp and owns shares of Celanese Corp (CE) stock worth about $1.71M. Mark Christopher Murray is the EVP, Biomaterials & AT of Avantor, Inc. and owns shares of Avantor, Inc. (AVTR) stock worth about $426.5K.
Signature
/s/ Blake Feikema, Attorney-in-Fact for Mark Christopher Murray
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Mark Christopher Murray and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Mark Christopher Murray has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,139,040.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Celanese Corp ($1,712,576).
  • Past-year value change for that position: +$161,545.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Mark Christopher Murray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CE Celanese Corp SVP - Acetyls $1,712,576 +$161,545 +10% 27 Feb 2026
AVTR Avantor, Inc. EVP, Biomaterials & AT $426,464 13 Jan 2022

Insider Transactions Reported by Mark Christopher Murray:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .